NCT02344719

Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis

The Effect of Oral Taurine on Portal Hemodynamics in Patients With Advanced

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Medical University of Vienna · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The investigators want to analyze the effect of Taurin on portal hemodynamics in patients with advanced liver cirrhosis.

Detailed description

28 days of 6 grams Taurine versus Placebo (randomization 1:1).

Conditions

• Cirrhosis
• Portal Hypertension

Interventions

Type	Name	Description
DRUG	Taurin 6g per day per oral for 28 days	Taurin 6g per day per oral for 28 days
PROCEDURE	HVPG Measurement baseline	On day 1 (baseline) and day 28 HVPG measurement will be performed
PROCEDURE	HVPG Measurement day 28	On day 1 (baseline) and day 28 HVPG measurement will be performed
DRUG	Placebo 6g per day per oral for 28 days	Placebo to Taurin 6g per day per oral for 28 days

Timeline

• Start date: 2010-10-01
• Primary completion: 2015-05-01
• Completion: 2015-06-01
• First posted: 2015-01-26
• Last updated: 2015-09-25

Locations

1 site across 1 country: Austria